Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Surgical Pathology|March 22, 2014
Whorled Urothelial Cell Carcinoma: A Neglected VariantCarlo Patriarca, Eva Comperat, Enrico Bollito, et al.
BJU International|December 21, 2010
Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patientsStephanie Oger, Delphine Behr-Roussel, Diane Gorny, et al.
Urologic Oncology|November 21, 2009
Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experienceFrançois Audenet, Eva Comperat, Elise Seringe, et al.
Asian Journal of Andrology|December 27, 2011
Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell culturesStéphane Larré, Philippe Camparo, Eva Comperat, et al.
European Radiology|March 20, 2019
MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?Salma Jendoubi, Mathilde Wagner, Sarah Montagne, et al.
Urology|January 30, 2018
Renal Pseudo-tumor Related to Renal Splenosis: Imaging FeaturesMickael Tordjman, David Eiss, Jonathan Dbjay, et al.
Virchows Archiv : an International Journal of Pathology|June 13, 2003
Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expressionFlorence Jourdan, Nicole Sebbagh, Eva Comperat, et al.
World Journal of Urology|November 13, 2010
Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre studyAlexandra Masson-Lecomte, Vincent Hupertan, Eva Comperat, et al.
BJU International|February 21, 2014
First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancerPierre Mozer, Morgan Rouprêt, Chloé Le Cossec, et al.
Ultrasound in Medicine & Biology|May 19, 2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic TreatmentsThomas Payen, Alexandre Dizeux, Capucine Baldini, et al.
Pageof 19